CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure

BACKGROUND: Mesenchymal stem cell (MSC) transplantation is emerging as a promising cell therapeutic strategy in acute liver failure (ALF) clinical research. The potency of MSCs to migrate and engraft into targeted lesions could largely determine their clinical efficacy, in which chemokine/receptor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ruixuan, Ni, Beibei, Wang, Li, Shan, Jiarou, Pan, Lijie, He, Yizhan, Lv, Guo, Lin, Huizhu, Chen, Wenjie, Zhang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817567/
https://www.ncbi.nlm.nih.gov/pubmed/35123561
http://dx.doi.org/10.1186/s13287-022-02729-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817567/
https://www.ncbi.nlm.nih.gov/pubmed/35123561
http://dx.doi.org/10.1186/s13287-022-02729-y

Ejemplares similares